Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
20112 | 412 | 41.0 | 90% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
728 | 12031 | BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF//NERVE GROWTH FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AZ64 | Author keyword | 3 | 100% | 1% | 3 |
2 | TROPOMYOSIN RECEPTOR KINASES | Author keyword | 3 | 100% | 1% | 3 |
3 | CEP 701 | Author keyword | 2 | 44% | 1% | 4 |
4 | VINCENT T LOMBARDI COMPREHENS CANC | Address | 2 | 36% | 1% | 5 |
5 | TROPOMYOSIN RECEPTOR KINASE | Author keyword | 2 | 43% | 1% | 3 |
6 | TROPOMYOSIN RELATED KINASE | Author keyword | 2 | 33% | 1% | 4 |
7 | CEP 2563 | Author keyword | 1 | 100% | 0% | 2 |
8 | ERI 8 | Address | 1 | 50% | 0% | 2 |
9 | TRK INHIBITORS | Author keyword | 1 | 100% | 0% | 2 |
10 | TRKB NTRK2 | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AZ64 | 3 | 100% | 1% | 3 | Search AZ64 | Search AZ64 |
2 | TROPOMYOSIN RECEPTOR KINASES | 3 | 100% | 1% | 3 | Search TROPOMYOSIN+RECEPTOR+KINASES | Search TROPOMYOSIN+RECEPTOR+KINASES |
3 | CEP 701 | 2 | 44% | 1% | 4 | Search CEP+701 | Search CEP+701 |
4 | TROPOMYOSIN RECEPTOR KINASE | 2 | 43% | 1% | 3 | Search TROPOMYOSIN+RECEPTOR+KINASE | Search TROPOMYOSIN+RECEPTOR+KINASE |
5 | TROPOMYOSIN RELATED KINASE | 2 | 33% | 1% | 4 | Search TROPOMYOSIN+RELATED+KINASE | Search TROPOMYOSIN+RELATED+KINASE |
6 | CEP 2563 | 1 | 100% | 0% | 2 | Search CEP+2563 | Search CEP+2563 |
7 | TRK INHIBITORS | 1 | 100% | 0% | 2 | Search TRK+INHIBITORS | Search TRK+INHIBITORS |
8 | TRKB NTRK2 | 1 | 100% | 0% | 2 | Search TRKB+NTRK2 | Search TRKB+NTRK2 |
9 | TRKS | 1 | 22% | 1% | 4 | Search TRKS | Search TRKS |
10 | TROPOMYOSIN RELATED KINASE B | 1 | 17% | 1% | 4 | Search TROPOMYOSIN+RELATED+KINASE+B | Search TROPOMYOSIN+RELATED+KINASE+B |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROTROPHIC RECEPTOR TRKB | 17 | 50% | 6% | 24 |
2 | PROTECTS NEUROBLASTOMA CELLS | 11 | 78% | 2% | 7 |
3 | FACTOR LIKE PROTEIN | 9 | 23% | 8% | 34 |
4 | NTRK1 NGF RECEPTOR | 9 | 83% | 1% | 5 |
5 | CEP 751 KT 6587 | 9 | 67% | 2% | 8 |
6 | CEP 701 KT 5555 | 6 | 80% | 1% | 4 |
7 | NEUROTROPHIC FACTOR ACTIVATION | 6 | 50% | 2% | 8 |
8 | CEP 701 | 4 | 67% | 1% | 4 |
9 | HEPARANASE PRODUCTION | 4 | 67% | 1% | 4 |
10 | NEUROTROPHIN RECEPTORS | 4 | 11% | 9% | 38 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Manipulation of the nerve growth factor network in prostate cancer | 2007 | 28 | 38 | 55% |
The role of nerve growth factor and its receptors in tumorigenesis and cancer pain | 2014 | 2 | 68 | 35% |
Trk kinase inhibitors as new treatments for cancer and pain | 2009 | 37 | 46 | 35% |
Neurotrophins and their receptors in breast cancer | 2012 | 15 | 97 | 39% |
The neurotrophic receptor TrkB in anoikis resistance and metastasis: A prespective | 2005 | 47 | 31 | 42% |
Perineural invasion and associated pain in pancreatic cancer | 2011 | 60 | 139 | 12% |
TrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders | 2013 | 10 | 152 | 13% |
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma | 2005 | 71 | 78 | 17% |
Nerve growth factor receptors and signaling in breast cancer | 2004 | 44 | 34 | 29% |
TrkB as a therapeutic target for ovarian cancer | 2009 | 10 | 97 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VINCENT T LOMBARDI COMPREHENS CANC | 2 | 36% | 1.2% | 5 |
2 | ERI 8 | 1 | 50% | 0.5% | 2 |
3 | U GROWTH TOR SIGNALING BREAST CANC CELLS FUNCT | 1 | 100% | 0.5% | 2 |
4 | GIGA INFECT IMMUN INFLAMMAT GRP | 1 | 50% | 0.2% | 1 |
5 | HN DIS | 1 | 50% | 0.2% | 1 |
6 | INNOVAT SURG LIFE SCI | 1 | 50% | 0.2% | 1 |
7 | IST CLIN ONCOL RIC TUMORI | 1 | 50% | 0.2% | 1 |
8 | LIFE PHYS SCI INTER E | 1 | 50% | 0.2% | 1 |
9 | SEZ DECENTRATA MESSINA | 1 | 50% | 0.2% | 1 |
10 | UNITA OPERAT CHIRURGIA TORAC | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000283616 | INSERM CJF 9313//OREGON REG PRIMATE NEUROSCI//ENDOCRINOL BIOL REPROD |
2 | 0.0000280125 | P75NTR//P75 NEUROTROPHIN RECEPTOR//PRONGF |
3 | 0.0000228831 | TANEZUMAB//NGF SECT//NEUROBIOL MOL MED |
4 | 0.0000136129 | NERVE GROWTH FACTOR//NEUROTROPHIN 3//NEUROTROPHIN |
5 | 0.0000119766 | JUXTAORAL ORGAN//PERINEURAL SPREAD//JUXTAORAL ORGAN OF CHIEVITZ |
6 | 0.0000087873 | NEUROBLASTOMA//MYCN//MYCN AMPLIFICATION |
7 | 0.0000072879 | NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE |
8 | 0.0000072295 | NEONEUROGENESIS//METASTASIS FORMATION//BP6 TU2 FIBROSARCOMA CELLS |
9 | 0.0000071236 | RUFFLE//PROTEIN KINASE N//PC12 MUTANT CELLS |
10 | 0.0000064327 | CANCER AND AIDS//CPG ISLETS//DNASE SENSITIVE CHROMATIN |